Epsilon Molecular Engineering, Inc.
PrivateLast Round
Series B
May 29, 2026
Est. Valuation
$20.35M
Total Funding Raised
$5.5M
Company Overview
Epsilon Molecular Engineering, Inc. operates in Healthcare & Life Sciences and is based in Saitama. Its latest recorded funding round was a Series B round in May 2026.
Epsilon Molecular Engineering, Inc. is a biotechnology company that conducts research and development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epsilon Molecular Engineering, Inc. Comparables
Compare Epsilon Molecular Engineering, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Isogenica | 83% | |
| Order-made Medical Research Inc. | 75% | |
| 株式会社イーベック | 72% |
For institutional investors. Book with your work email.
Epsilon Molecular Engineering, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 29, 2026 | ||||
| Series A | Dec 23, 2020 | ||||
| Seed | Nov 13, 2017 |
For institutional investors. Book with your work email.
Epsilon Molecular Engineering, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 株式会社日本政策金融公庫 | Series B |
| Mitsubishi UFJ Capital | Series A |
| UntroD Capital Japan Inc. | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 11, 2024
Monthly visitors increased 280% MoM, reaching 9.5K.
- Dec 23, 2020
$5.5M round led by Mitsubishi UFJ Capital.
For institutional investors. Book with your work email.
Epsilon Molecular Engineering, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Epsilon Molecular Engineering, Inc.'s valuation, stock price, and market status.
Is Epsilon Molecular Engineering, Inc. a public or private company?
Epsilon Molecular Engineering, Inc. is a private company.
What is the current stock price of Epsilon Molecular Engineering, Inc.?
Epsilon Molecular Engineering, Inc. is a private company, so its shares have no public market price. Caplight tracks Epsilon Molecular Engineering, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Epsilon Molecular Engineering, Inc. worth (valuation)?
Epsilon Molecular Engineering, Inc.'s valuation is estimated at $20.4M based on funding round data.
Can I buy Epsilon Molecular Engineering, Inc. stock?
Epsilon Molecular Engineering, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Epsilon Molecular Engineering, Inc.'s last funding round?
Epsilon Molecular Engineering, Inc.'s most recent funding round was Series B on May 29, 2026.
Who are the main investors in Epsilon Molecular Engineering, Inc.?
Key investors in Epsilon Molecular Engineering, Inc. include Mitsubishi UFJ Capital.
Will Epsilon Molecular Engineering, Inc. IPO soon?
No public IPO plans have been announced for Epsilon Molecular Engineering, Inc..
How can I track Epsilon Molecular Engineering, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Epsilon Molecular Engineering, Inc.'s shares on secondary markets.